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Abstract: Organotin compounds are chemicals that are widely used in industry 
and agriculture as plastic stabilizers, catalysts and biocides. Many of them, 
including tributyltin (TBT), have been detected in human food and, as  
a consequence, detectable levels have been found in human blood. As organotin 
compounds were shown to possess immunotoxic activity, we focused our 
attention on the effect of TBT on the basic determinants of the function of 
eosinophils, i.e. cell adhesiveness and motility. We used human eosinophylic 
leukemia EoL-1 cells, a common in vitro cellular model of human eosinophils. 
Here, we demonstrate that TBT causes a dose-dependent decrease in the 
viability of EoL-1 cells. When administered at sub-lethal concentrations, TBT 
significantly decreases the adhesion of EoL-1 cells to human fibroblasts (HSFs) 
and inhibits their migration on fibroblast surfaces. Since the basic function of 
eosinophils is to invade inflamed tissues, our results indicate that TBT, and 
possibly other organotin compounds, may affect major cellular properties 
involved in the determination of in vivo eosinophil function.  
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Butyltins have a broad range of applications. They are often used in industry as 
plastic stabilizers, catalysts and antifouling keel paints, and in agriculture as 
biocides. Humans are exposed to these chemicals primarily through the intake of 
food. Butyltins, including tributyltin (TBT), have been detected in human blood 
at concentrations ranging between 50 and 400 nM [1]. With the increased usage 
of these compounds, considerable attention has been focused on their potential 
toxicity. It has been shown that butyltins are highly hepatotoxic, neurotoxic 
and/or immunotoxic [2-4]. However, the specific mechanisms responsible for 
the immunotoxic effects of TBT are still unclear. For instance, to the best of our 
knowledge, the role of TBT in the regulation of eosinophil function has not been 
elucidated.  
Eosinophils are multi-functional cells that play a crucial role in various 
pathological events. Their activation is mainly associated with parasitic 
infections or allergic manifestations, and it depends on cell extravasation, which 
is a multi-step process that includes endothelial layer transmigration and the 
migration of eosinophils towards locally inflamed tissue [5]. The immunotoxicity 
of TBT has been demonstrated [1-4]. In this study, we investigated the effect of 
tributyltin on the basic cellular functions involved in eosinophil activity in vivo, 
namely the adhesion and motile activity of human eosinophylic leukemia EoL-1 
cells. This cell line has the cytological features of myeoloblasts and can 
differentiate phenotypically and functionally into eosinophils, thus providing an 
in vitro model for studying human eosinophil function and their regulation [6-7]. 
 
MATERIALS AND METHODS 
 
Cell culture 
A human eosinophilic leukemia (EoL-1) cell line was established from the 
peripheral blood of a patient with acute myeloid leukemia. Cells were cultured in 
RPMI-1640 medium (Sigma, St. Louis, MO/USA) supplemented with 10% FCS 
(Gibco, Lab., New York, USA), 100 IU/ml penicillin and 10 μg/ml streptomycin 
(Polfa, Tarchomin, Poland) in a humidified atmosphere with 5% CO2 at 37ºC. 
Human skin fibroblasts (HSFs) were cultured in MEM (Sigma, St. Louis, 
MO/USA) supplemented with 10% FCS, 100 IU/ml penicillin and 10 μg/ml 
streptomycin in a humidified atmosphere with 5% CO2 at 37ºC. 
 
Cell viability  
To determine the effect of TBT (Sigma, St. Louis, MO/USA) on the cell 
viability, EoL-1 cells were plated to 6-well plates at a density of 160,000/cm2 in 
the culture medium without TBT or with different concentrations of TBT in the 
range between 6.25 and 100 nM. They were cultured for 24 hours in  
a humidified atmosphere with 5% CO2 at 37ºC. Then the fluoresceine diacetate 
and ethidium bromide tests were applied [8]. 
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EoL-1 cells suspended in RPMI-1640 medium with 10% FCS without TBT or 
with 6.25 or 12.5 nM TBT were seeded at a density of 160,000/cm2 onto plastic 
or the surface of a monolayer of HSFs. They were cultured for 24 hours in  
a humidified atmosphere with 5% CO2 at 37ºC. Then the percentage of cells 
attached to the substrata was calculated as described previously [9]. 
 
Time lapse-monitoring of cell movement 
Time-lapse monitoring of cell movement was carried out as described previously 
[10]. 24 hours before the experiment, EoL-1 cells were seeded onto the surface 
of a monolayer of HSFs at a density of 125,000/cm2 and cultured in RPMI-1640 
medium supplemented with 10% FCS in a humidified atmosphere with 5% CO2 
at 37ºC. Immediately before the experiment, coverslips were placed into Sykes-
Moore chambers. Cell movement in the  culture medium was recorded at 37ºC 
for 5 hours with a 5 minute time-lapse interval under an inverted Olympus IMT-
2 microscope. Afterwards, the culture medium containing TBT (at a final 
concentration of 6.25 nM) was added, and recording was continued for a further 
5 hours. Individual cell tracks were determined by changes in the cell centroid 
position, and plotted in circular diagrams. Parameters characterizing cell 




Statistical significance was determined using the non-parametric Mann-Whitney 
U-test with p </0.05 considered to indicate significant differences. The value of 
each of the variables characterising the motility was calculated for 50 cells. Each 
variable was expressed as the mean of 3-6 independent experiments.  
 
RESULTS AND DISCUSSION 
 
Several studies demonstrated that TBT affects the viability of a wide range of 
normal and tumour cells [13-16]. To examine the effect of TBT on EoL-1 cell 
viability, in the first series of experiments, the cells were incubated with TBT in 
concentrations ranging from 6.25 to 100 nM for 24 hours, and the percentage of 
viable cells was calculated. As shown in Fig. 1, TBT at concentrations at and 
above 25 nM exerted a potent cytotoxic effect on EoL-1 cells. 
EoL-1 cells cultured in vitro are anchorage-independent; they do not adhere to 
glass or plastic, but grow in suspension (data not shown). This corresponds to 
the behaviour of eosinophils in vivo, where they persist in the circulation with  
a half-life of 6-12 hours. The recruitment of eosinophils into sites of 
inflammation includes adhesion, endothelial cell layer transmigration and 
migration of eosinophils towards locally inflamed tissue. Tissue infiltration by 
eosinophils provides an opportunity for direct interactions with resident 
fibroblasts, which may in turn serve to support eosinophil survival, adhesion, 
activation and secretion [4, 17-20].  
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Therefore, in further experiments we investigated the effect of TBT on the 
adhesion of EoL-1 cells to HSFs at non-toxic concentrations, i.e. those not 
affecting cell viability (6.25 and 12.5 nM). 
  
 
Fig. 1. The effect of TBT on the viability of EoL-1 cells. Cells were treated with TBT for 
24 hours and then the percentage of viable cells was calculated. Error bars represent SD,  






Fig. 2. The effect of TBT on EoL-1 cell attachment to the surfaces of the underlying HSFs. 
A – Cells were incubated without TBT or with 6.25 or 12.5 nM TBT for 24 hours, and the 
percentage of cells attached to the substrata was calculated. B, C, D – Nomarski`s 
differential interference contrast. Error bars represent SD, *indicates statistical significance 
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As shown in Fig. 2, over 45% of EoL-1 cells adhered to the surface of HSFs 
after 24 hours of incubation in the control medium. The treatment of cells with 
6.25 or 12.5 nM TBT for 24 hours caused a significant and concentration-
dependent decrease in the fraction of adherent EoL-1 cells. In the presence of 
12.5 nM TBT, only 8.1 ± 1.6% adhered to the surface of HSFs; therefore, we 
subsequently concentrated on the effect of 6.25 nM TBT on the motile activity 
of EoL-1 cells. The trajectories of the investigated cells moving on the surfaces 
of the underlying HSFs in control conditions and in the presence of TBT are 
shown in Fig. 3A, B, and the quantitative data is summarized in Tab. 1.  
 
 
Fig. 3. The effect of TBT on the migration of EoL-1 cells moving on the surfaces of the 
underlying HSFs. Cell movement was recorded for 5 hours at 5-minute intervals. 
Afterwards, 6.25 nM TBT was added and the recording of cell locomotion was continued 
for a further 5 hours. The composite trajectories of EoL-1 cells migrating in (A) the control 
medium, and (B) the medium containing 6.25 nM TBT are shown in circular diagrams.  
C –  A plot of the average instantaneous velocity of the EoL-1 cells. The arrow shows the 
point at which 6.25 nM TBT was added.  
 
Tab. 1. A summary of the quantitative data showing the effect of TBT on the migration                
of EoL-1 cells on the surfaces of the underlying HSFs. 
 
Parameters (± SEM) Control 6.25 nM TBT 
Average speed of cell movement  [μm/min]  0.9 ± 0.03 0.7 ± 0.02* 
Total cell displacement [μm] 46.4 ± 4.7 37.8 ± 3.8* 
 
   *significant at p < 0.05 compared to the control 
 
It was found that 6.25 nM TBT caused a significant decrease in the average 
speed of cell locomotion (to 77% of the control) and in the total length of cell 
displacement (to 81% of the control). Moreover, analysis of the instantaneous 
velocity of EoL-1 revealed that under control conditions, the values of this 
parameter remained unchanged over the entire duration of the experiment. By 
contrast, upon administration of 6.25 nM TBT, a gradual decrease in the 
instantaneous velocity was observed (Fig. 3C).  
In summary, these results demonstrate that TBT is cytotoxic to EoL-1 cells at 
concentrations of 25 nM and above. Moreover, at non-toxic concentrations, this 
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compound significantly inhibits the adhesion of EoL-1 cells to HSFs, and their 
motile activity (< 25 nM). The accumulation of eosinophils in tissues is one of 
the most important aspects in non-allergic and allergic inflammatory reactions, 
and eosinophil recruitment is regulated by several processes including cell 
adhesion and migration. Thus, our results indicate that TBT, commonly used in 
agriculture and industry, can significantly affect the biological functions of EoL-
1 cells in vitro at very low concentrations, suggesting that TBT can interfere 
with the vital physiological functions of eosinophils.  
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